959.Wilson C., Nix J., Szostak J. Functional requirements for specific ligand recognition by a biotin-binding RNA pseudoknot // Biochemistry. 1998. V.37. P.14410-14419.
960.Wilson C., Szostak J.W. In vitro evolution of a self-alkylating ribozyme // Nature. 1995. V.374. P.777-782.
961.Wilson C., Szostak J.W. Isolation of a fluorophore-specific DNA aptamer with weak redox activity // Chem. Biol. 1998. V.5. P.609-617.
962.3. Wilson D.S., Szostak J.W. In vitro selection of functional nucleic acids // Annu. Rev. Biochem. 1999. V.68. P.611–647.
963.Win M.N., Klein J.S., Smolke C.D. Codeine-binding RNA aptamers and rapid determination of their binding constants using a direct coupling surface plasmon resonance assay // Nucleic Acids Research. 2006. V.34. P.5670-5682.
964.Win M.N., Smolke C.D. A modular and extensible RNA-based gene-regulatory platform for engineering cellular function // PNAS. 2007. V.104. P.14283-14288.
965.Winkler W.C., Breaker R.R. Regulation of bacterial gene expression by riboswitches // Annu. Rev. Microbiol. 2005. V.59. P.487–517.
966.Winkler W.C., Breaker R.R. Genetic control by metabolite-binding riboswitches // Chembiochem. 2003. V.4. P.1024–1032.
967.Winkler W.C., Cohen-Chalamish S., Breaker R.R. An mRNA structure that controls gene expression by binding FMN // Proc. Natl Acad. Sci. USA. 2002. V.99. P.15908–15913.
968.Winkler W., Nahvi A., Breaker R.R. Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression // Nature. 2002. V.419. P.952–956.
969.Winkler W.C., Nahvi A., Roth A., Collins J.A., Breaker R.R. Control of gene expression by a natural metabolite-responsive ribozyme // Nature. 2004. V.428. P.281–286.
970.Winkler W.C., Nahvi A., Sudarsan N., Barrick J.E., Breaker R.R. An mRNA structure that controls gene expression by binding S-adenosylmethionine // Nat. Struct. Biol. 2003. V.10. P.701–707.
971.Wlotzka B., Leva S., Eschgfaller B., Burmeister J., Kleinjung F., Kaduk C., Muhn P., Hess-Stumpp H., Klussmann S. In vivo properties of an anti-GnRH Spiegelmer: an
156
example of an oligonucleotide-based therapeutic substance class // Proc. Natl. Acad.
Sci. USA. 2002. V.99. P.8898-8902.
972.Woese C.R., Winker S., Gutell R.R. // Proc. Natl. Acad. Sci. USA. 1990. V.87. P.8467.
973.Wright M.C., Joyce G.F. Continuous in vitro evolution of catalytic function // Science. 1997. V.276. P.614-617.
974.Wu H.N., Lin Y.J., Lin F.P., Makino S., Chang M.F., Lai M.M. Human hepatitis delta virus RNA subfragments contain an autocleavage activity // Proc. Natl Acad. Sci. USA. 1989. V.86. P.1831–1835.
975.Wu L.H., Curran J.F. An allosteric synthetic DNA // Nucleic Acids Res. 1999. V.27. P.1512–1516.
976.Wurster S.E., Maher III L.J. Selection and characterization of anti-NF-{kappa}B p65 RNA aptamers // RNA. 2008. V.14. P.1037-1047.
977.Xayaphoummine A., Viasnoff V., Harlepp S., Isambert H. Encoding folding paths of RNA switches // Nucleic Acids Res. 2007. V.35. P.614-622.
978.Xu W., Ellington A.D. Anti-peptide aptamers recognize amino acid sequence and bind a protein epitope // Proc. Natl. Acad. Sci. USA. 1996. V.93. P.7475-7480.
979.Xu X., Hamhouyia F., Thomas S.D., Burke T.J., Girvan A.C., McGregor W.G., Trent J.O., Miller D.M., Bates P.J. Inhibition of DNA Replication and Induction of S Phase Cell Cycle Arrest by G-rich Oligonucleotides // J. Biol. Chem. 2001. V.276. P.43221-43230.
980.Yamamoto R., Katahira M., Nishikawa S., Baba T., Taira K., Kumar P.K. A novel RNA motif that binds efficiently and specifically to the Tat protein of HIV and inhibits the trans-activation by Tat of transcription in vitro and in vivo // Genes Cells. 2000. V.5. P.371-388.
981.Yamamoto-Fujita R., Kumar P.K.R. Aptamer-derived nucleic acid oligos: applications to develop nucleic acid chips to analyze proteins and small ligands // Anal. Chem. 2005. V.77. P.5460–5466.
982.Yang C.J., Jockusch S., Vicens M., Turro N.J., Tan W. Light-switching excimer probes for rapid protein monitoring in complex biological fluids // PNAS. 2005. V.102. P.17278-17283.
157
983.Yang C., Yan N., Parish J., Wang X., Shi Y., Xue D. RNA Aptamers Targeting the Cell Death Inhibitor CED-9 Induce Cell Killing in Caenorhabditis elegans // J. Biol. Chem. 2006. V.281. P.9137-9144.
984.Yang Q., Goldstein I.J., Mei H.Y., Engelke D.R. DNA ligands that bind tightly and selectively to cellobiose // Proc. Natl Acad. Sci. USA. 1998. V.95. P.5462–5467.
985.Yang W., Wang Q., Howell K.L., Lee J.T., Cho D.S., Murray J.M., Nishikura K. ADAR1 RNA deaminase limits short interfering RNA efficacy in mammalian cells // J. Biol. Chem. 2005. V.280. P.3946–3953.
986.Yang Y., Kochoyan M., Burgstaller P., Westhof E., Famulok M. Structural basis of ligand discrimination by two related RNA aptamers resolved by NMR spectroscopy // Science. 1996. V.272. P.1343–1347.
987.Yarus M. RNA-ligand chemistry: a testable source for the genetic code // RNA. 2000. V.6. P.475-484.
988.Ye X., Gorin A., Ellington A.D., Patel D.J. Deep penetration of an alpha-helix into a widened RNA major groove in the HIV-1 rev peptide-RNA aptamer complex // Nat. Struct. Biol. 1996. V.3. P.1026-1033.
989.Ye X, et al. // Chem. Biol. 1999. V.6. P.657.
990.Ye X., Kumar R.A., Patel D.J. // Chem. Biol. 1995. V.2. P.827.
991.Yen L., Svendsen J., Lee J.S., Gray J.T., Magnier M., Baba T., D'Amato R.J., Mulligan R.C. Exogenous control of mammalian gene expression through modulation of RNA self-cleavage // Nature. 2004. V.431. P.471–476.
992.Ylera F., Lurz R., Erdmann V.A., Furste J.P. Selection of RNA aptamers to the Alzheimer's disease amyloid peptide // Biochem. Biophys. Res. Commun. 2002. V.290. P.1583-1588.
993.Yoshizawa S., Fourmy D., Puglisi J.D. // EMBO J. 1998. V.17. P.6437.
994.Zamore P.D., Haley B. Ribo-gnome: The big world of small RNAs // Science. 2005. V.309. P.1519–1524.
995.Zhang B., Cech T.R. Peptide bond formation by in vitro selected ribozymes // Nature. 1997. V.390. P.96-100.
996.Zhang H., Kolb F.A., Jaskiewicz L., Westhof E., Filipowicz W. Single processing center models for human Dicer and bacterial RNase III // Cell. 2004. V.118. P.57–68.
158
997.Zhang L., Kasif S., Cantor A.C.R. Quantifying DNA-protein binding specificities by using oligonucleotide mass tags and mass spectroscopy // PNAS. 2007. V.104. P.3061-3066.
998.Zhang Q., Sun X., Watt E.D., Al-Hashimi H.M. Resolving the Motional Modes That Code for RNA Adaptation // Science. 2006. V.311. P.653-656.
999.Zhu L., Anslyn E.V. Signal amplification by allosteric catalysis // Angew. Chem. Int. Ed. Engl. 2006. V.45. P.1190–1196.
1000. Zhuang X., Bartley L.E., Babcock H.P., Russell R., Ha T., Herschlag D., Chu S. A single-molecule study of RNA catalysis and folding // Science. 2000. V.288. P.2048– 2051.
1001. Zimmermann G.R., Jenison R.D., Wick C.L., Simorre J.P., Pardi A. Interlocking structural motifs mediate molecular discrimination by a theophylline-binding RNA // Nat. Struct. Biol. 1997. V.4. P.644–649.
1002. Zimmermann G.R., Shields T.P., Jenison R.D., Wick C.L., Pardi A. A semiconserved residue inhibits complex formation by stabilizing interactions in the free state of a theophylline-binding RNA // Biochemistry. 1998. V.37. P.9186-9192.
1003. Zimmermann G.R., Wick C.L., Shields T.P., Jenison R.D., Pardi A. Molecular interactions and metal binding in the theophylline-binding core of an RNA aptamer // RNA. 2000. V.6. P.659-667.
1004. Zivarts M., Liu Y., Breaker R.R. Engineered allosteric ribozymes that respond to specific divalent metal ions // Nucleic Acids Res. 2005. V.33. P.622-631.
1005. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction // Nucleic Acids Res. 2003. V.31. P.3406–3415.
1006. Zuker M. Computer prediction of RNA structure // Methods Enzymol. 1989. V.183. P.202–287.
1007. http://aptamer.icmb.utexas.edu/
1008. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie // Science. 1982. V.216. P.136–144.
1009. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E. Conversion of alpha-helices into beta-sheets
159
features in the formation of the scrapie prion proteins // Proc. Natl. Acad. Sci. USA. 1993. V.90. P.10962–10966.
1010. Huang Z., Gabriel J.M., Baldwin M.A., Fletterick R.J., Prusiner S.B., Cohen F.E. Proposed three-dimensional structure for the cellular prion protein // Proc. Natl. Acad. Sci. USA. 1994. V.91. P.7139–7143.
1011. Cohen F.E., Pan K.M., Huang Z., Baldwin M., Fletterick R.J., Prusiner S.B. Structural clues to prion replication // Science. 1994. V.264. P.530–531.
1012. Scott M., Foster D., Mirenda C., Serban D., Coufal F., Walchli M., Torchia M., Groth D., Carlson G., DeArmond S.J. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques // Cell. 1989. V.59. P.847–857.
1013. Saborio G.P., Permanne B., Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding // Nature. 2001. V.411. P.810– 813.
1014. Castilla J., Saa P., Hetz C., Soto C. In vitro generation of infectious scrapie prions // Cell. 2005. V.121. P.195–206.
1015. Gajdusek D.C. The transmissible amyloidoses: genetical control of spontaneous generation of infectious amyloid proteins by nucleation of configurational change in host precursors: kuru-CJD-GSS-scrapie-BSE // Eur. J. Epidemiol. 1991. V.5. P.567– 577.
1016. Prusiner S.B., McKinley M.P., Groth D.F., Bowman K.A., Mock N.I., Cochran S.P., Masiarz F.R. Scrapie agent contains a hydrophobic protein // Proc. Natl. Acad. Sci. USA. 1981. V.78. P.6675–6679.
1017. McKinley M.P., Bolton D.C., Prusiner S.B. A protease-resistant protein is a structural component of the scrapie prion // Cell. 1983. V.35. P.57–62.
1018. Bolton D.C., McKinley M.P., Prusiner S.B. Identification of a protein that purifies with the scrapie prion // Science. 1982. V.218. P.1309–1311.
1019. Yokoyama T., Kimura K.M., Ushiki Y., Yamada S., Morooka A., Nakashiba T., Sassa T., Itohara S. In vivo conversion of cellular prion protein to pathogenic isoforms, as monitored by conformation-specific antibodies // J. Biol. Chem. 2001. V.276. P.11265–11271.
160